A new clinical trial proves low level laser therapy (LLLT) devices effective in treating male and female pattern hair loss. These devices are now available to South Florida residents at Hair Transplant Institute of Miami.
Miami, FL (PRWEB) February 27, 2014
Participants saw an average increase of about 20 terminal hairs per square centimeter of scalp after using the HairMax LaserComb™ [LLLT device].
For the first time, low level laser therapy (LLLT) devices prove successful in stimulating new hair growth in men and women who suffer with androgenetic alopecia, or pattern hair loss. In a clinical trial of 122 women and 103 men, participants saw an average increase of about 20 terminal hairs per square centimeter of scalp after using the HairMax LaserComb™ for just 26 weeks*.
Professionals are particularly excited by the results because they were produced by a randomized, double-blind study. Neither participants nor administrators knew the critical aspects of the study under such quality controls, nearly eliminating both experimenter bias and potential placebo effect.
Background: Most men and women are shocked to learn that pattern hair loss is actually a chronic dermatologic disorder (of the skin). Leading research indicates that pattern baldness stems from hair follicle miniaturization, a phenomenon thought to be caused by hormonal imbalance and increase production of DHT. This condition causes hair follicles to shrink over time, eventually becoming unable to sustain natural hair growth.
Hair follicle miniaturization appears to be the most common cause of hair loss in both men and women. The most effective non-surgical hair loss treatments focus on slowing or reversing the miniaturization process. Well known treatments include medications like Propecia® and topical minoxidil foam, typically purchased under the brand name Rogaine®.
Most recently, low level laser therapy (LLLT) devices have received acclaim from hair surgeons and patients alike for their safe, non-surgical, and convenient approach to treating pattern baldness. LLLT devices are designed to reawaken dormant or “miniaturized” hair follicles through photobiomodulation, a biological process that induces cellular activity, repair, and growth. When applied to the scalp, this randomized, double-blind study provides the first clinical evidence that laser hair restoration works for both men and women.
*Dr. Paul Rose and Dr. Bernard Nusbaum of the Hair Transplant Institute of Miami are excited to spread awareness among both current patients and South Florida residents for this new study, inviting all to learn more by downloading the PDF here.
For more information on personal-use laser hair restoration devices, readers are invited to call the Institute at 877-443-9070 or visit Miamihair.com to learn more about the HairMax LaserComb™ and the Capillus 272 LLLT device for hair loss.